Dabigatran as an oral anticoagulant in patients with Budd–Chiari syndrome post‐percutaneous endovascular intervention-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dabigatran as an oral anticoagulant in patients with Budd–Chiari syndrome post‐percutaneous endovascular intervention

Published:2019-11-25 Issue:4 Volume:35 Page:654-662
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Sharma Sanchit¹,Kumar Ramesh²^ORCID,Rout Gyanranjan¹,Gamanagatti Shivanand R³,Shalimar ¹^ORCID

Affiliation:

1. Department of GastroenterologyAll India Institute of Medical Sciences, New Delhi New Delhi India

2. Department of GastroenterologyAll India Institute of Medical Sciences, Patna Patna Bihar India

3. Department of RadiodiagnosisAll India Institute of Medical Sciences, New Delhi New Delhi India

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.14843

Reference31 articles.

1. Vascular disorders of the liver

2. Budd‐Chiari syndrome

3. Vitamin K Antagonists – Current Concepts and Challenges

4. The Relative Cost-Effectiveness of Anticoagulants

5. Time in therapeutic range;Gateman D;Can. Fam. Physician,2017

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Splanchnic Vein Thrombosis: The State-of-the-Art on Anticoagulant Treatment;Hämostaseologie;2024-02-14

2. Efficacy and safety of direct oral anticoagulants in splanchnic vein thrombosis: a pooled analysis of literature studies;Journal of Thrombosis and Haemostasis;2024-02

3. Effect of Direct Oral Anticoagulants in Patients with Splanchnic Vein Thrombosis: A Systematic Reviews and Meta-Analysis;Clinical and Applied Thrombosis/Hemostasis;2024-01

4. Primary Budd-Chiari syndrome versus sinusoidal obstruction syndrome: a review;Current Medical Research and Opinion;2023-12-13

5. Direct oral anticoagulants for the treatment of splanchnic vein thrombosis: A state of art;World Journal of Gastroenterology;2023-09-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3